XML 21 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 1,100 $ 1,531
Accounts receivable, net of allowance for doubtful accounts of $50 million and $52 million, respectively (Note 2) 3,564 3,433
Inventories (Note 3) 2,485 2,340
Other current assets (Note 4) 576 480
Total current assets 7,725 7,784
Long-term assets:    
Property, net 3,545 3,495
Operating lease, right-of-use assets 443 451
Investments in affiliates (Note 21) 1,651 1,723
Intangible assets, net (Note 2) 2,534 2,585
Goodwill (Note 2) 5,099 5,106
Other long-term assets (Note 4) 719 740
Total long-term assets 13,991 14,100
Total assets 21,716 21,884
Current liabilities:    
Short-term debt (Note 8) 45 31
Accounts payable 2,996 3,150
Accrued liabilities (Note 5) 1,467 1,684
Total current liabilities 4,508 4,865
Long-term liabilities:    
Long-term debt (Note 8) 6,473 6,460
Pension benefit obligations 368 354
Long-term operating lease liabilities 355 361
Other long-term liabilities (Note 5) 740 750
Total long-term liabilities 7,936 7,925
Total liabilities 12,444 12,790
Commitments and contingencies (Note 10)
Balance of redeemable noncontrolling interest 97 96
Shareholders' equity:    
Preferred shares, $0.01 par value per share, 50,000,000 shares authorized; 11,500,000 shares of 5.50% Mandatory Convertible Preferred Shares, Series A, issued and outstanding as of March 31, 2023 and December 31, 2022. 0 0
Ordinary shares, $0.01 par value per share, 1,200,000,000 shares authorized, 270,718,099 and 270,949,579 issued and outstanding as of March 31, 2023 and December 31, 2022, respectively 3 3
Additional paid-in capital 3,972 3,989
Retained earnings 5,690 5,608
Accumulated other comprehensive loss (Note 13) (682) (791)
Total Aptiv shareholders' equity 8,983 8,809
Noncontrolling interest 192 189
Total shareholders' equity 9,175 8,998
Total liabilities, redeemable noncontrolling interest and shareholders' equity $ 21,716 $ 21,884